250 related articles for article (PubMed ID: 15509713)
1. Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein.
Baek SJ; Kim JS; Moore SM; Lee SH; Martinez J; Eling TE
Mol Pharmacol; 2005 Feb; 67(2):356-64. PubMed ID: 15509713
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities.
Baek SJ; Kim KS; Nixon JB; Wilson LC; Eling TE
Mol Pharmacol; 2001 Apr; 59(4):901-8. PubMed ID: 11259636
[TBL] [Abstract][Full Text] [Related]
3. NAG-1 up-regulation mediated by EGR-1 and p53 is critical for quercetin-induced apoptosis in HCT116 colon carcinoma cells.
Lim JH; Park JW; Min DS; Chang JS; Lee YH; Park YB; Choi KS; Kwon TK
Apoptosis; 2007 Feb; 12(2):411-21. PubMed ID: 17191121
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma.
Worden B; Yang XP; Lee TL; Bagain L; Yeh NT; Cohen JG; Van Waes C; Chen Z
Cancer Res; 2005 Aug; 65(16):7071-80. PubMed ID: 16103054
[TBL] [Abstract][Full Text] [Related]
5. Activation of nonsteroidal anti-inflammatory drug-activated gene-1 via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase revealed a isochaihulactone-triggered apoptotic pathway in human lung cancer A549 cells.
Chen YL; Lin PC; Chen SP; Lin CC; Tsai NM; Cheng YL; Chang WL; Lin SZ; Harn HJ
J Pharmacol Exp Ther; 2007 Nov; 323(2):746-56. PubMed ID: 17715378
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase inhibitors induce apoptosis in oral cavity cancer cells by increased expression of nonsteroidal anti-inflammatory drug-activated gene.
Kim KS; Yoon JH; Kim JK; Baek SJ; Eling TE; Lee WJ; Ryu JH; Lee JG; Lee JH; Yoo JB
Biochem Biophys Res Commun; 2004 Dec; 325(4):1298-303. PubMed ID: 15555568
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced expression of nonsteroidal anti-inflammatory drug-activated gene/macrophage inhibitory cytokine-1/prostate-derived factor, a putative tumor suppressor, inhibits tumor growth.
Martinez JM; Sali T; Okazaki R; Anna C; Hollingshead M; Hose C; Monks A; Walker NJ; Baek SJ; Eling TE
J Pharmacol Exp Ther; 2006 Aug; 318(2):899-906. PubMed ID: 16714403
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of activating transcription factor 3 involves the early growth response-1 gene.
Bottone FG; Moon Y; Alston-Mills B; Eling TE
J Pharmacol Exp Ther; 2005 Nov; 315(2):668-77. PubMed ID: 16079301
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase inhibitors induce apoptosis in sinonasal cancer cells by increased expression of nonsteroidal anti-inflammatory drug-activated gene.
Kim JH; Chang JH; Rhee KH; Yoon JH; Kwon SH; Song K; Lee KW; Cho CI; Jeon JH; Kim KS
Int J Cancer; 2008 Apr; 122(8):1765-73. PubMed ID: 18076062
[TBL] [Abstract][Full Text] [Related]
10. Early Growth Response-1 gene mediates up-regulation of epidermal growth factor receptor expression during hypoxia.
Nishi H; Nishi KH; Johnson AC
Cancer Res; 2002 Feb; 62(3):827-34. PubMed ID: 11830539
[TBL] [Abstract][Full Text] [Related]
11. Zinc finger transcription factor Egr-1 is involved in stimulation of NHE2 gene expression by phorbol 12-myristate 13-acetate.
Malakooti J; Sandoval R; Memark VC; Dudeja PK; Ramaswamy K
Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G653-63. PubMed ID: 15976391
[TBL] [Abstract][Full Text] [Related]
12. Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1.
Baek SJ; Kim JS; Nixon JB; DiAugustine RP; Eling TE
J Biol Chem; 2004 Feb; 279(8):6883-92. PubMed ID: 14662774
[TBL] [Abstract][Full Text] [Related]
13. EGR-1, the reluctant suppression factor: EGR-1 is known to function in the regulation of growth, differentiation, and also has significant tumor suppressor activity and a mechanism involving the induction of TGF-beta1 is postulated to account for this suppressor activity.
Liu C; Calogero A; Ragona G; Adamson E; Mercola D
Crit Rev Oncog; 1996; 7(1-2):101-25. PubMed ID: 9109500
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of early growth response-1 and its role in uterine leiomyoma growth.
Shozu M; Murakami K; Segawa T; Kasai T; Ishikawa H; Shinohara K; Okada M; Inoue M
Cancer Res; 2004 Jul; 64(13):4677-84. PubMed ID: 15231681
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal modulation between Sp1 and Egr-1.
Huang RP; Fan Y; Ni Z; Mercola D; Adamson ED
J Cell Biochem; 1997 Sep; 66(4):489-99. PubMed ID: 9282327
[TBL] [Abstract][Full Text] [Related]
16. HGF induces fibronectin matrix synthesis in melanoma cells through MAP kinase-dependent signaling pathway and induction of Egr-1.
Gaggioli C; Deckert M; Robert G; Abbe P; Batoz M; Ehrengruber MU; Ortonne JP; Ballotti R; Tartare-Deckert S
Oncogene; 2005 Feb; 24(8):1423-33. PubMed ID: 15608673
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression and activity of the immediate-early growth response (Egr-1) gene product during cellular senescence.
Meyyappan M; Wheaton K; Riabowol KT
J Cell Physiol; 1999 Apr; 179(1):29-39. PubMed ID: 10082129
[TBL] [Abstract][Full Text] [Related]
18. Expression of early growth response genes in human prostate cancer.
Eid MA; Kumar MV; Iczkowski KA; Bostwick DG; Tindall DJ
Cancer Res; 1998 Jun; 58(11):2461-8. PubMed ID: 9622090
[TBL] [Abstract][Full Text] [Related]
19. Regulation of expression of the early growth response gene-1 (EGR-1) in malignant and benign cells of the prostate.
Mora GR; Olivier KR; Mitchell RF; Jenkins RB; Tindall DJ
Prostate; 2005 May; 63(2):198-207. PubMed ID: 15486985
[TBL] [Abstract][Full Text] [Related]
20. Changes in gene expression contribute to cancer prevention by COX inhibitors.
Baek SJ; Eling TE
Prog Lipid Res; 2006 Jan; 45(1):1-16. PubMed ID: 16337272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
